| MicroRNA targeting to modulate tumor microenvironment PR Kuninty, J Schnittert, G Storm, J Prakash Frontiers in oncology 6, 3, 2016 | 135 | 2016 |
| ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer PR Kuninty, R Bansal, SWL De Geus, DF Mardhian, J Schnittert, ... Science advances 5 (9), eaax2770, 2019 | 116 | 2019 |
| MicroRNA-199a and-214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor PR Kuninty, L Bojmar, V Tjomsland, M Larsson, G Storm, A Östman, ... Oncotarget 7 (13), 16396, 2016 | 95 | 2016 |
| Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer J Schnittert, MA Heinrich, PR Kuninty, G Storm, J Prakash Cancer letters 420, 247-258, 2018 | 66 | 2018 |
| Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC C Strell, KJ Norberg, A Mezheyeuski, J Schnittert, PR Kuninty, CF Moro, ... British journal of cancer 117 (1), 65-77, 2017 | 45 | 2017 |
| Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cells J Schnittert, PR Kuninty, TF Bystry, R Brock, G Storm, J Prakash Nanomedicine 12 (12), 1369-1384, 2017 | 35 | 2017 |
| Cancer immune therapy using engineered‛ tail-flipping’nanoliposomes targeting alternatively activated macrophages PR Kuninty, K Binnemars-Postma, A Jarray, KP Pednekar, MA Heinrich, ... Nature communications 13 (1), 4548, 2022 | 29 | 2022 |
| SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells PS Kowalski, PR Kuninty, KT Bijlsma, MCA Stuart, NGJ Leus, MHJ Ruiters, ... European journal of pharmaceutics and biopharmaceutics 89, 40-47, 2015 | 15 | 2015 |
| Microarchitectural mimicking of stroma-induced vasculature compression in pancreatic tumors using a 3D engineered model MA Heinrich, I Uboldi, PR Kuninty, MJK Ankone, J van Baarlen, YS Zhang, ... Bioactive Materials 22, 18-33, 2023 | 10 | 2023 |
| ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer. Sci Adv. 2019; 5 (9): eaax2770 PR Kuninty, R Bansal, SWL De Geus, DF Mardhian, J Schnittert, ... | 6 | |
| MicroRNA targeting to modulate tumor microenvironment. Front Oncol. 2016 PR Kuninty, J Schnittert, G Storm, J Prakash | 3 | 2016 |
| Targeting integrin alpha5 receptor in pancreatic stellate cells to diminish tumor-promoting effects in pancreatic cancer PR Kuninty, R Bansal, SWL De Geus, J Schnittert, J van Baarlen, G Storm, ... bioRxiv, 350678, 2018 | 2 | 2018 |
| Abstract B208: Targeting ITGA5 in pancreatic stellate cells as a novel strategy to restrain pancreatic tumor growth P Kuninty, S de Geus, R Bansal, J Schnittert, P Kuppen, A Vahrmeijer, ... Molecular Cancer Therapeutics 17 (1_Supplement), B208-B208, 2018 | 1 | 2018 |
| PO-009 A novel integrin alpha 5 binding peptide potentiates effects of chemotherapy in pancreatic cancer PR Kuninty, R Bansal, TN Satav, MF Bijlsma, HV Laarhoven, A Östman, ... ESMO Open 3, A230-A231, 2018 | | 2018 |
| 150 MicroRNA-199a and 214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor PR Kuninty, L Bojmar, P Sandström, G Storm, J Prakash European Journal of Cancer 51, S14-S15, 2015 | | 2015 |
| 176 Specific targeting of anti-miRNA oligonucleotides to pancreatic stellate cells via a syndecan dependent uptake mechanism J Schnittert, PR Kuninty, J Prakash, G Storm European Journal of Cancer 51, S22, 2015 | | 2015 |
| Peptide-based nucleic acid delivery methods to mesenchymal cells. J Prakash, J Schnittert, PR Kuninty US Patent App. 62/222,332, 2015 | | 2015 |
| S22 Abstracts J Schnittert, PR Kuninty, J Prakash, G Storm | | |